IBO Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Impact Biomedical Inc

Watchlist Manager

Watchlist

Price: 0.54 USD 12.5% Market Closed

Market Cap: $58.2m

I	Impact Biomedical Inc AMEX:IBO	US
	Ampol Ltd ASX:ALD	AU
S	SynBiotic SE XMUN:SBX	DE
A	Arnoldo Mondadori Editore SpA SWB:MDD	IT
I	Industrias CH SAB de CV SWB:AKQ	MX
Y	YANGAROO Inc OTC:YOOIF	CA
F	FnGuide Inc KOSDAQ:064850	KR
A	algoWatt SpA SWB:TI5	IT
S	Service Industries Ltd KAR:SRVI	PK
L	Lucy Scientific Discovery Inc OTC:DOSEF	CA
G	Golden Pursuit Resources Ltd OTC:FPVTF	CA
	Uranium Royalty Corp F:59U	CA

Profitability Summary

Impact Biomedical Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

66%

Sustainable 3Y Average Gross Margin

29%

Negative Operating Margin

-14 597%

Negative 3Y Average Operating Margin

-115 997%

Exceptional Net Margin

2 254%

Negative 3Y Average Net Margin

-158 820%

Negative Free Cash Flow Margin

-1 451%

Negative 3Y Average Free Cash Flow Margin

-16 116%

Exceptional ROE

371%

Negative 3Y Average ROE

-165%

Negative ROIC

-30%

Negative 3Y Average ROIC

-48%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.